Today’s panel will delve into groundbreaking technologies, medical devices and pharmaceuticals in various stages of development to combat cancer. Joining us today are Gerard Michel, CEO of Delcath Technologies, ticker DCTH on the NASDAQ; as well as Dr. Anatoly Dritschilo, CEO of Shuttle Pharmaceuticals, ticker SHPH.

This KOL Panel was recorded at the Lytham Partners Spring 2023 Investor Conference.